HHS Pick Price Made ‘Brazen’ Stock Trades While His Committee Was Under Scrutiny
With federal investigators bearing down on his committee, Rep. Tom Price, who is in line to be secretary of HHS, showed little restraint in investing in health companies.
Women Fear Drug They Used To Halt Puberty Led To Health Problems
Despite questions about Lupron’s lasting side effects and minimal study into its safety, the FDA sped approval of the drug to market. Years later, some young women are still living with the consequences.
Democrats Say Cabinet Choice Tom Price ‘Misled’ The Public. Here’s What We Know.
Concerns over U.S. Rep. Tom Price’s answers about stock trades led Senate Democrats to boycott a committee vote that would have moved his nomination to the Senate floor.
Trump’s HHS Choice: First A Letter To Medicare. Then A Campaign Contribution
Rep. Tom Price, up for running HHS under President Trump, helped a company that became a top campaign donor, records show.
Trump’s HHS Pick Favored Drugmakers, Device Makers And Doctors
Letters sent to Medicare from U.S. Rep. Tom Price, President Trump’s pick to run HHS, supported physicians as well as drug or device makers, records show.
Top Price Contributor Allegedly Leaned On Employees To Support PAC
President-elect Donald Trump’s Cabinet pick Tom Price “assisted” a company and campaign donor who tapped executives with an urgent request to donate.
Trump’s Health Secretary Nominee Sought Special Treatment for Industry Donors
Rep. Tom price advocated on everything from a sperm test to a hot pepper ingredient on behalf of medical interests that include campaign donors.
Hospitals And Surgery Centers Play Tug-Of-War Over America’s Ailing Knees
As Medicare considers paying for knee replacement procedures outside the hospital, doctors debate patient choice and the potential for post-operation complications.
Price Poised To Protect Doctors’ Interests At HHS
As a Republican congressman, orthopedic surgeon Tom Price introduced bills to protect doctors’ financial interests.
Deadly Infections Linked To Heart Surgery Device Highlight Holes In FDA Monitoring
The federal agency took 14 months to warn the public about the potential for infections. Officials say they acted as fast as they could.